Codexis (CDXS) Depreciation & Amortization (CF) (2010 - 2026)
Codexis (CDXS) recorded quarterly Depreciation & Amortization (CF) of $1.3 million in Q1 2026, down 5.23% quarter-over-quarter from $1.4 million in Q4 2025, and up 7.62% on a YoY basis from $1.2 million in Q1 2025.
Codexis (CDXS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Codexis' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 7.62% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $5.3 million (up 9.2% YoY), while the FY2025 annual figure was $5.2 million, up 6.11% from the prior year.
- Depreciation & Amortization (CF) was $1.3 million for Q1 2026 at Codexis, down from $1.4 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q2 2023 to a low of $1.2 million in Q1 2025.
- Historically, Depreciation & Amortization (CF) has averaged $1.3 million across 5 years, with a median of $1.3 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 87.29% in 2022, then slipped 15.61% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.4 million in 2022, then declined by 15.61% to $1.2 million in 2023, then retreated by 0.58% to $1.2 million in 2024, then grew by 12.24% to $1.4 million in 2025, then slipped by 5.23% to $1.3 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $1.3 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 429,663.65 |
| 10 | Codexis | 226.01 Mn | 160.87 Mn | 13.18 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |